Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Tovaxin in Subjects With CIS or RR-MS

NCT00245622 is registered in ClinicalTrials.gov with Opexa Therapeutics, Inc. as lead sponsor.

NCT NCT00245622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Tovaxin in Subjects With CIS or RR-MS
Lead sponsor
Opexa Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
September 30, 2008
Enrollment
150 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis